News

AllRock Bio Presents Phase 1 Data for Lead Program, ROC-101, at the ERS Congress

29th September 2025

AllRock Bio Announces $50 Million Series A to Advance Lead Clinical Program for Pulmonary Hypertension

16th September 2025

Top